Why is Gennex Lab. falling/rising?

As of 14-Jul, Gennex Laboratories Ltd is experiencing a price increase, currently at 14.82, with a change of 0.23, representing a rise of 1.58%. The stock has shown strong performance recently, gaining 19.81% over the last six days and outperforming its sector by 0.68% today. Additionally, the stock has outperformed the benchmark Sensex over the past week, with a return of +19.04% compared to the Sensex's -1.42%. The company benefits from a low debt-to-equity ratio and healthy long-term growth, with operating profit increasing at an annual rate of 56.07%. However, there is a concern regarding the increase in pledged promoter shares, which currently stands at 23.87%.
In the broader market context, while Gennex Laboratories has shown significant short-term gains, its year-to-date performance is down by 9.30%, contrasting with the Sensex's increase of 5.27%. Despite this, the stock has outperformed the BSE500 over the last three years, one year, and three months, indicating a strong long-term performance. The company's return on equity is relatively low at 9.4%, which, along with flat quarterly results, raises questions about management efficiency. Overall, while the stock is currently rising, it faces challenges that could impact its future performance.